MCET (MultiCell Technologies) LT-Debt-to-Total-Asset: 0.00 (As of Aug. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MultiCell Technologies LT-Debt-to-Total-Asset?

MultiCell Technologies MCET -90.00% LT-Debt-to-Total-Asset is 0.00 as of Aug. 2015.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. MultiCell Technologies's long-term debt to total assests ratio for the quarter that ended in Aug. 2015 was 0.00.

MultiCell Technologies's long-term debt to total assets ratio declined from Aug. 2014 (0.26) to Aug. 2015 (0.00). It may suggest that MultiCell Technologies is progressively becoming less dependent on debt to grow their business.

MultiCell Technologies  (OTCPK:MCET) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

MultiCell Technologies LT-Debt-to-Total-Asset Related Terms

MultiCell Technologies LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for MultiCell Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MultiCell Technologies LT-Debt-to-Total-Asset Chart

MultiCell Technologies Annual Data
Trend Nov05 Nov06 Nov07 Nov08 Nov09 Nov10 Nov11 Nov12 Nov13 Nov14
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.08 0.27 0.00 0.29

MultiCell Technologies Quarterly Data
Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.29 0.00 0.00 0.00

MultiCell Technologies LT-Debt-to-Total-Asset Calculation

MultiCell Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Nov. 2014 is calculated as

LT Debt to Total Assets (A: Nov. 2014 )=Long-Term Debt & Capital Lease Obligation (A: Nov. 2014 )/Total Assets (A: Nov. 2014 )
=0.036/0.126
=0.29

MultiCell Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Aug. 2015 is calculated as

LT Debt to Total Assets (Q: Aug. 2015 )=Long-Term Debt & Capital Lease Obligation (Q: Aug. 2015 )/Total Assets (Q: Aug. 2015 )
=0/0.296
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
MultiCell Technologies (MCET) has a LT-Debt-to-Total-Asset of 0.00 as of Aug. 2015. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on MultiCell Technologies and its competitors.
Is MultiCell Technologies' LT-Debt-to-Total-Asset too high?
MultiCell Technologies' current LT-Debt-to-Total-Asset is 0.00.
How does MultiCell Technologies' LT-Debt-to-Total-Asset compare to ERGO and OPLI?
MultiCell Technologies' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on MultiCell Technologies and its competitors. MultiCell Technologies's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MultiCell Technologies stock overvalued right now?
MultiCell Technologies (MCET) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For MultiCell Technologies (MCET), the current LT-Debt-to-Total-Asset is 0.00 as of Aug. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MultiCell Technologies Business Description

Address 4144 North Central Expressway, Suite 600, Dallas, TX, USA, 75204
MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize, and differentiate stem cells from the human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.